Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
University of Zurich
Biotech
Muvon flexes muscle cell data to challenge incontinence implants
Muvon linked its cell therapy to a 60% drop in incontinence frequency, leading the biotech to aim to reduce reliance on synthetic material implants.
Nick Paul Taylor
Dec 3, 2025 8:19am
Animal studies rarely lead to approvals, new research finds
Jun 17, 2024 11:20am
Immune dysfunction link to long COVID opens door to therapies
Jan 19, 2024 6:00am
Immunotherapies targeting 2 peptides blast fibrosis in mice
Sep 16, 2022 3:20pm
New immuno-oncology combo attacks glioblastoma in mice
Oct 7, 2020 2:00pm
Boosting I-O drugs by recruiting immune messenger cells
Sep 21, 2020 8:25am
